Bellevue Funds (Lux) -Bellevue Obesity Solutions I USD - Accumulating/  LU0415392751  /

Fonds
NAV16/05/2024 Var.-1.5000 Type of yield Focus sugli investimenti Società d'investimento
582.7400USD -0.26% reinvestment Equity Worldwide Waystone M.Co.(Lux) 

Investment strategy

The Fund invests at least two thirds of the net assets of Bellevue Biotech in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries. Without restricting the scope of the term "biotechnology", the companies within the entire value chain in the biotechnology sector consist especially of companies that prepare, develop, utilise, market and/or sell processes, methods, technologies and products in which organisms, cells or cell constituents are used. Up to one third of the net assets can be invested in debt securities of private and government issuers with various terms and credit ratings. The Fund may engage in derivative transactions in order to achieve an efficient portfolio management, in particular also for hedging purposes.
 

Investment goal

The Fund invests at least two thirds of the net assets of Bellevue Biotech in a portfolio of carefully chosen shares and other equity securities of companies in the biotechnology industry or companies whose main activity involves holding investments in such companies or financing such companies and that have their registered office or carry out the majority of their economic activity in recognised countries.
 

Dati master

Type of yield: reinvestment
Fondi Categoria: Equity
Region: Worldwide
Settore: Sector Biotechnology
Benchmark: MSCI World Healthcare NR
Business year start: 01/07
Ultima distribuzione: -
Banca depositaria: CACEIS Investor Services Bank
Domicilio del fondo: Luxembourg
Permesso di distribuzione: Austria, Germany, Switzerland, United Kingdom, Luxembourg
Gestore del fondo: Christian Lach, Lukas Leu, Oliver Kubli
Volume del fondo: 36.73 mill.  USD
Data di lancio: 31/03/2009
Investment focus: -

Condizioni

Sovrapprezzo emissione: 5.00%
Tassa amministrativa massima: 0.90%
Investimento minimo: - USD
Deposit fees: -
Redemption charge: 0.00%
Prospetto semplificato: Download (Print version)
 

Società d'investimento

Funds company: Waystone M.Co.(Lux)
Indirizzo: 19, rue de Bitbourg, 1273, Luxemburg
Paese: Luxembourg
Internet: www.waystone.com
 

Attività

Stocks
 
98.45%
Cash and Other Assets
 
1.55%

Paesi

United States of America
 
66.17%
Denmark
 
9.36%
Switzerland
 
5.82%
United Kingdom
 
5.62%
Germany
 
1.99%
Sweden
 
1.50%
Ireland
 
1.39%
Spain
 
1.18%
Netherlands
 
1.07%
France
 
0.93%
India
 
0.85%
Brazil
 
0.82%
Japan
 
0.78%
China
 
0.75%
Cayman Islands
 
0.22%
Altri
 
1.55%

Filiali

Pharma/Biotechnology
 
47.55%
Healthcare services
 
21.94%
Healthcare appliances
 
16.04%
Parma, wholesale
 
4.21%
amusement parks
 
1.89%
Cash / other assets
 
1.55%
Leisure articles
 
1.50%
Clothing
 
1.27%
consumer electronics
 
1.15%
Computer Hardware
 
1.07%
Grocery Producers
 
0.93%
Gesundheitswesen/ Informationstechnologie
 
0.90%